Search

everythinglearnresearchcommunity

for

Search:↓

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

General anesthesia might be linked to certain types of hair loss, but more research is needed.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Hair loss significantly influences medical decisions, affecting treatment choices and emotional well-being.

Many LGBTQ individuals in Lahore face skin issues, with androgenic alopecia, dry skin, and scabies being common, highlighting the need for better healthcare access and provider training.

Timely treatments like PRP, topical, and drugs can effectively reduce hair loss.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

Australia needs better dermatological guidelines for gender-diverse patients.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

A girl with a rare genetic disorder had a unique bone condition, highlighting the need for careful diagnosis and suggesting the disorder might be more common than thought.

CT scans can find serious prostate cancer even when PSA levels are low.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

Plucked hair follicles grow faster than conventional ones, making them a potentially better option for hair transplants.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

PRP might be a good treatment for hair loss, but more research is needed to be sure.

PRP injections improve skin and hair quality, boost self-esteem, and are safe and satisfying for patients.

Early diagnosis of pseudopelade of Brocq in men is crucial to prevent permanent hair loss.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Waxing and epilation might help wound healing, but more research is needed.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Stand-alone PRP therapy effectively increases hair density for hair loss treatment.

Hair-Thread Tourniquet Syndrome is a rare condition where hair or thread tightly wraps around a child's body part, requiring quick treatment to prevent damage.

Hair loss in women aged 20-30 is often linked to deficiencies in Vitamin D, zinc, ferritin, and haemoglobin, as well as low SHBG levels in those with irregular periods.

Combining PRP with a special lotion is more effective for hair loss than PRP alone.

Early surgical treatment for severe facial injuries from high-energy impacts leads to better recovery.

HSL treatment speeds up hair growth and reduces oxidative stress in hair follicles of ob/ob mice.

Platelet-rich plasma (PRP) effectively improves skin aging with minimal risk.